Waymo’s robotaxis are under investigation for passing stopped school buses

The NHTSA's Office of Defects Investigation has opened a probe into Waymo's fifth-generation self-driving system after the Austin Independent School District documented 19 instances this school year of Waymo robotaxis passing stopped school buses (at least five occurrences after a purported software update). Federal regulators have requested detailed technical information and whether Waymo has halted operations during school pick-up/drop-off; Waymo says it will file a voluntary software recall and has issued fixes while pointing to a stronger overall safety record. The inquiry and local requests to cease operations create regulatory and operational risk for Waymo as it expands into new markets, with potential reputational and compliance implications for Alphabet's autonomous-vehicle business.

Analysis

Market structure: Short-term winners are legacy OEMs and suppliers (Velodyne/MPLY? and Mobileye/MBLY) who can argue for slower, regulated rollouts; losers are Waymo/Alphabet (GOOGL/GOOG) autonomy revenue timing and small AV pure-plays that lack balance-sheet resilience. Expect city permit frictions to push Waymo’s rollout timeline out 12–24 months, reducing near-term ordering for L4 sensors/compute by an estimated 10–20% in affected cities. Cross-asset: modest rise in GOOGL implied volatility (historly +5–15% on regulatory headlines), negligible impact on Treasuries or commodities but potential 1–2% widening in tech credit spreads for smaller AV suppliers if probe escalates.

Risk assessment: Tail risks include an NHTSA finding that forces a city-level suspension or a formal recall costing $100–$500M, class actions, or state bans that delay revenue indefinitely. Immediate (days) risk: share-price spikes and option vol; short-term (weeks–months): regulatory hearings and voluntary recall details; long-term (quarters–years): higher compliance costs and slower TAM penetration but core ad/cloud earnings remain intact. Hidden dependencies: insurance rate increases, municipal permit reciprocity, and mapping/data-license limitations that could amplify costs.

Trade implications: Tactical hedges favored over outright de-grossing of Alphabet: buy 3-month GOOG/GOOGL puts (≈7–10% OTM) sized to cover 1–2% portfolio risk within 5 trading days; simultaneously, maintain or trim core Alphabet equity exposure by no more than 2–3% given ads/cloud stability. Pair trade: short small-cap AV supplier (identify based on leverage) vs long MSFT (defensive tech/cloud) to capture flight-to-quality; consider 6–9 month vertical put spreads to cap premium outlay.

Contrarian angle: Consensus conflates Waymo headline risk with Alphabet’s entire franchise—historical probes (2024) produced transient price moves but no durable earnings impairment. Overreaction would create a 3–5% buying opportunity in GOOG/GOOGL if NHTSA’s recall is limited (cost < $200M) and no city bans follow within 90 days. Unintended consequence: stricter rules raise entry barriers, advantaging deep-pocket players (Alphabet, GM/Cruise) over startups, so small tactical hedges plus selective accumulation on confirmed regulatory de-risking is optimal.

Key Decisions for Investors

• Buy 3-month GOOG or GOOGL puts ~7.5% OTM sized to hedge 1–2% of portfolio equity risk; enter within 5 trading days and exit if NHTSA closes probe with no enforcement action within 90 days.
• Maintain core Alphabet exposure but reduce net long by 2–3% (rotate proceeds into MSFT by 1–2%) to capture relative safety in cloud revenue and limit autonomy headline risk.
• Establish a pair trade: short a highly leveraged small/mid-cap AV supplier (select names with >50% revenue concentration in L4/autonomy) vs long MSFT (equal notional) for 6–9 months to exploit flight-to-quality; size to 1–2% net portfolio risk.
• If NHTSA voluntary recall cost is disclosed < $200M and no municipal bans announced in 60 days, accumulate GOOG/GOOGL up to an incremental 3% weight; if recall > $300M or city suspensions in >1 major market, increase hedges to cover 3–4% risk.